[Technical methodologic aspects of clinical dosimetry in radionuclide therapy]
- PMID: 2179659
[Technical methodologic aspects of clinical dosimetry in radionuclide therapy]
Abstract
The paper is devoted to the solution of problems related to clinical dosimetry in radiation therapy with open radionuclides, i.e. technical methodological problems of measurement of an absorbed therapeutic dose of radiation in targets in volume distribution of a radionuclide. The developed methods and means of measurement include a large activity radiometer for measuring therapeutic and diagnostic activities, a topometric ultrasound unit (Aloka) and software. The main features of the method were illustrated on a clinical example of the assessment of an absorbed therapeutic dose of 131I radiation in thyroid tissue during therapy of patients with thyrotoxicosis. The accuracy of the method was assessed.
Similar articles
-
3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.Radiat Prot Dosimetry. 2012 Jul;150(3):298-305. doi: 10.1093/rpd/ncr411. Epub 2011 Nov 7. Radiat Prot Dosimetry. 2012. PMID: 22069233
-
Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy.Cancer Biother Radiopharm. 2002 Feb;17(1):107-18. doi: 10.1089/10849780252824127. Cancer Biother Radiopharm. 2002. PMID: 11915167 Review.
-
Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.J Nucl Med. 2004 Oct;45(10):1725-33. J Nucl Med. 2004. PMID: 15471841 Clinical Trial.
-
Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges.Acta Oncol. 2006;45(8):1031-6. doi: 10.1080/02841860600635888. Acta Oncol. 2006. PMID: 17118834
-
Dosimetry of internal emitters.J Nucl Med. 2005 Jan;46 Suppl 1:18S-27S. J Nucl Med. 2005. PMID: 15653648 Review.